Fraser v. Williams

61 F. Supp. 763, 66 U.S.P.Q. (BNA) 482, 1945 U.S. Dist. LEXIS 2057
CourtDistrict Court, E.D. Wisconsin
DecidedJuly 14, 1945
Docket1403
StatusPublished
Cited by2 cases

This text of 61 F. Supp. 763 (Fraser v. Williams) is published on Counsel Stack Legal Research, covering District Court, E.D. Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Fraser v. Williams, 61 F. Supp. 763, 66 U.S.P.Q. (BNA) 482, 1945 U.S. Dist. LEXIS 2057 (E.D. Wis. 1945).

Opinion

DUFFY, District Judge.

Plaintiffs bring this action for alleged infringement of the trade-mark, trade name, and trade brand “RU-EX” and 'also for unfair competition. Defendant by counterclaim makes similar charges against the plaintiffs with reference to his trademark and trade name “RUX.” Both RU-EX and RUX were and are used to designate pharmaceutical products in powder form for the treatment of rheumatism.

The defendant has established by abundant evidence, including documentary, proof, his adoption and use of the name R.U.X. for his product as early as January, 1934, and the continuous use thereafter, first in the form of R.U.X., and after the latter part of 1936 as RUX. The principal sales of RUX have been on the West Coast and in various States west of the Mississippi River, although it also has been distributed in .most of the other States. The largest volume of sales was between 1937-1941 inclusive, with 1938 being the peak year. R.U.X. and RUX were advertised principally over the radio and in newspapers and magazines. RUX was usually referred to as Rux Compound. During the same period defendant marketed another remedy known as Williams S.L.K. Formula, a stomachic.

As to the adoption and use of RU-EX prior to 1934, plaintiffs are forced to rely almost entirely upon the recollection of witnesses. Thai plaintiffs’ business predecessor sold RU-EX in Canada in December, 1934, was sufficiently proved however. A Canadian license dated September 26, 1934, was granted to Ru-Ex Remedy Company of Toronto, Canada, and a certificate of registration was issued to the same company on November 2, 1934. The Canadian business was conducted solely in Canada, the labels and supplies being purchased there. A Canadian firm name and address were used.

It is doubtful that such proof is sufficient to establish in plaintiffs the exclusive trade-mark rights to the name in the United States. Moxie Co. v. Noxie Kola Co. of New York, D.C., 29 F.Supp. 167; Le Blume Import Co., Inc. v. Coty, 2 Cir., 293 F. 344. In any event the date of the Canadian sales' is subsequent to the time when defendant had adopted and used R.U.X. in the United States.

Plaintiffs insist, however, that the sales in Canada show that the product had been successfully tried -out at an earlier date in this country, and that a Chicago manufacturer would not undertake to market a remedy in Canada which had not first been established in the United States. While such is a permissible conclusion, it is one which does not necessarily follow. In a letter dated June 5, 1941, plaintiffs’ business predecessor who supervised the Canadian business said, “There is one thing about Canada, it is good testing ground.”

Any rights which the plaintiffs may have to the exclusive use of RU-EX stem from Charles G. Foucek who was the proprietor of a drug store at 1801 South Racine Avenue in Chicago. Foucek was of Bohemian nationality, and prior to 1924, in addition to the retail sales at his drug store, carried on a small mail order business in pharma *765 ceutical preparations with others of his nationality, referred to in the testimony as the “Bohemian trade.” He advertised in Czech almanacs and sent out catalogues to those replying, listing about twenty remedies. No catalogue or advertisement was produced wherein the name of RU-EX was used, but witnesses were produced who recalled that in the days when he operated his drug store, Foucek had a liquid preparation for rheumatism called “Rum-ix” and also a powdered preparation which he sometimes designated as RU-EX or Ru-Ex Powder.

Milton W. Folds, son of C. G. Foucek, was associated with his father during most of the period from 1917 to 1941. In 1924 the father sold ithe drug store at 1801 South Racine Avenue. From 1924 to 1929 he conducted a laboratory at 1832 South Racine Avenue, and one at 1020 South Wabash Avenue from 1929 to 1931, and another at 510 North Dearborn Street for a portion of the year in 1931, but separated from his son and opened a store and laboratory on Blue Island Avenue in the latter part of 1931; thereafter, from 1933 to 1940, he conducted a laboratory at 3635 West Cermak Road, at which place his son was again associated with him. The business relationship between father and son was somewhat informal. The son claimed ito be a partner and testified, “We acted as partners, like father and son would. We always had a verbal partnership agreement.”

The principal product made and sold by Foucek was Aurine Ear Balm. Fou-cek carried on the business sometimes under his own name but usually under the name of Aurine Remedy Company. Later an Illinois corporation was formed under the name, Aurine Co., Inc. Milton Folds devoted most of his time to promoting the sale of Aurine Ear Balm, especially after the father sold the drug store in 1924.

In addition to Milton Folds, the principal witnesses for plaintiffs were Miss Loy who was employed by Aurine Remedy Company from 1929 to 1932, and from late 1933 to the present time, and witness Michalek who was employed by Foucek from 1919 to 1933. Both testified that one of the remedies sold was RU-EX. In answer to the following leading question, “Did Mr. Foucek put on those rheumatic powders some trade-mark, the same trademark which is shown on. this label, Exhibit 1, namely ‘RU-EX ?’ ” Michalek testified, “Well, the old man had several different names for the same. Sometimes he would call it ‘RU-EX’ and sometimes he would call it ‘Foucek’s Rheumatic Powders,’ and he had different terms to call it, it was not consistent, but he did call it, I recall, ‘RU-EX’ and I also recall ‘Rheumatic Powders.’ ”

Exhibit 1 referred to is a small partially printed and partially typewritten label. “Foucek’s Premium Prescription” is printed across the top, under which, on separate line's, the words “No.,” “Remedy For,” and “Directions,” are printed, each followed by a line for an insert, and the words “RU-EX,” “Rheumatism,” and “Follow Directions Enclosed In Box” are respectively typewritten in the blank spaces. Not much weight can be given to the label itself, as the name RU-EX easily could have been typewritten on an old unused label long after Foucek sold his store in 1924. In fact the testimony disclosed that on occasions some old labels had been used after plaintiffs’ predecessors moved to a new location, but usually the address was then altered. However, Exhibit 8 is a label which contains the printed name RU-EX as well as directions for the use of the powder with the juice of four lemons. At the foot of the label appears “Aurine Remedy Company, 1020 So. Wabash Ave., Chicago.” This is the only documentary proof that the name RU-EX was used by Foucek at all prior to the defendant’s adoption and use of RUX in 1934.

The use of the term RU-EX on a remedy for rheumatism was old, as is shown by the trade-mark registration No. 116896 by Albert S. Glass under date of June 5, 1917. The basis for trade-mark rights is the association in the public mind of the mark with the goods. American Photographic Pub. Co. v. Ziff-Davis Pub. Co., 7 Cir., 135 F.2d 569, 573. Something more than mere adoption is essential. The use must be general, continuous, exclusive, and applied to the goods and used in trade under such circumstances of publicity and length of use as to show intention to adopt the mark for specific goods. Continental Corporation v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Dill Mfg. Co. v. J. W. Speaker Corp.
83 F. Supp. 21 (E.D. Wisconsin, 1949)

Cite This Page — Counsel Stack

Bluebook (online)
61 F. Supp. 763, 66 U.S.P.Q. (BNA) 482, 1945 U.S. Dist. LEXIS 2057, Counsel Stack Legal Research, https://law.counselstack.com/opinion/fraser-v-williams-wied-1945.